The Largest Pharma Fraud Whistleblower Case in U.S. History

January 15, 2009

"Psych News" <psych_newsJanuary 15, 2009 12:22:02 PM HST"Psych News " <Psych_NewsThe Largest Pharma Fraud Whistleblower Case in U.S. History Lilly agrees to settle criminal investigation over the psych drug Zyprexa. How much did your state get? Reported so far: Florida $35.6 Million Ohio $32.1 Million Texas $30 Million Missouri $18 Million Kansas $1.1 Milion Wall Street JournalLilly Reaches Zyprexa SettlementBy KERRY E. GRACE January 15, 2009Eli Lilly & Co. agreed to pay $1.42 billion in a long-awaited settlement with federal prosecutors regarding allegations of improperly marketing its blockbuster antipsychotic drug Zyprexa. A resolution has been expected since October, when the Indianapolis drug maker announced it was in "advanced discussions" and had set aside the settlement's amount, a record sum in a corporate whistleblower case, for an eventual settlement in the case.The company said Thursday it will pay $615 million to settle a criminal investigation and nearly $800 million -- $438 million to the federal government and $362 million available for settlements with states -- to resolve civil investigations related to Zyprexa.As part of the settlement with the Justice Department, Lilly agreed to plead guilty to one misdemeanor violation of the Food, Drug and Cosmetic Act related to the off-label promotion of Zyprexa between 1999 and 2001. The guilty plea says Lilly promoted the drug in elderly people as treatment for dementia, including Alzheimer's, although the drug isn't approved for such use.The company said it disagrees with and doesn't admit to the allegations, but would settle the dispute. General Counsel Robert A. Armitage noted in October the probe "has been ongoing for five years and we now have a heightened sense of responsibility to all our stakeholders to intensify efforts to resolve these issues."Lilly will also face a period of increased regulation as part of the settlement -- it has entered a corporate integrity agreement with the Health and Human Services Department. The agreement requires the company to maintain its compliance program and undertake a set of obligations related to integrity over five years. The deal also provides for a third-party review of the company's policies...Insurers, pension funds and unions have been among those seeking compensation from Lilly, accusing it of concealing Zyprexa's tendency to cause weight gain and diabetes and of marketing the drug for unapproved uses Source: http://online.wsj.com/article/SB123201838370585347.html?mod=googlenews_wsj 28,085 Signatures Against TeenScreen. Petition: http://www.petitiononline.com/TScreen/petition.html Video:

=========In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.

January 15, 2009

Lilly agrees to settle criminal investigation over the psych drug Zyprexa. How much did your state get?

Reported so far:

Florida

$35.6 Million

Ohio

$32.1 Million

Texas

$30 Million

Missouri

$18 Million

Kansas

$1.1 Milion

Wall Street JournalLilly Reaches Zyprexa SettlementBy KERRY E. GRACE

January 15, 2009Eli Lilly & Co. agreed to pay $1.42 billion in a long-awaited settlement with federal prosecutors regarding allegations of improperly marketing its blockbuster antipsychotic drug Zyprexa.

A resolution has been expected since October, when the Indianapolis drug maker announced it was in "advanced discussions" and had set aside the settlement's amount, a record sum in a corporate whistleblower case, for an eventual settlement in the case.The company said Thursday it will pay $615 million to settle a criminal investigation and nearly $800 million -- $438 million to the federal government and $362 million available for settlements with states -- to resolve civil investigations related to Zyprexa.As part of the settlement with the Justice Department, Lilly agreed to plead guilty to one misdemeanor violation of the Food, Drug and Cosmetic Act related to the off-label promotion of Zyprexa between 1999 and 2001. The guilty plea says Lilly promoted the drug in elderly people as treatment for dementia, including Alzheimer's, although the drug isn't approved for such use.The company said it disagrees with and doesn't admit to the allegations, but would settle the dispute. General Counsel Robert A. Armitage noted in October the probe "has been ongoing for five years and we now have a heightened sense of responsibility to all our stakeholders to intensify efforts to resolve these issues."Lilly will also face a period of increased regulation as part of the settlement -- it has entered a corporate integrity agreement with the Health and Human Services Department. The agreement requires the company to maintain its compliance program and undertake a set of obligations related to integrity over five years. The deal also provides for a third-party review of the company's policies...Insurers, pension funds and unions have been among those seeking compensation from Lilly, accusing it of concealing Zyprexa's tendency to cause weight gain and diabetes and of marketing the drug for unapproved uses

Source: http://online.wsj.com/article/SB123201838370585347.html?mod=googlenews_wsj

28,085 Signatures Against TeenScreen. Petition: http://www.petitiononline.com/TScreen/petition.html Video:

January 21, 2009

What I want to know is how will this money be spent? General budgets????? Wasted like the tobacco money????

I think that the states should be sued by the people for misuse of funds when they are awarded these huge payouts then spend like drunken sailors without any regulation of said funds. I wonder if there are any BOLD and BRAVE state reps out there who would make laws and actually pass them that would hold states accountable to the people?

I must still be "pixilated" from that Faery slide show to think any of this will happen!

LoriSchooling is not education, and education is not schooling~John Taylor Gatto

herbal remedies From: Informed_ConsentDate: Thu, 15 Jan 2009 18:06:12 -0500{Herbal Remedies} The Largest Pharma Fraud Whistleblower Case in U.S. History

Lilly agrees to settle criminal investigation over the psych drug Zyprexa. How much did your state get?

Reported so far:

Florida

$35.6 Million

Ohio

$32.1 Million

Texas

$30 Million

Missouri

$18 Million

Kansas

$1.1 Milion

Wall Street JournalLilly Reaches Zyprexa SettlementBy KERRY E. GRACE

January 15, 2009Eli Lilly & Co. agreed to pay $1.42 billion in a long-awaited settlement with federal prosecutors regarding allegations of improperly marketing its blockbuster antipsychotic drug Zyprexa.

A resolution has been expected since October, when the Indianapolis drug maker announced it was in "advanced discussions" and had set aside the settlement's amount, a record sum in a corporate whistleblower case, for an eventual settlement in the case.The company said Thursday it will pay $615 million to settle a criminal investigation and nearly $800 million -- $438 million to the federal government and $362 million available for settlements with states -- to resolve civil investigations related to Zyprexa.As part of the settlement with the Justice Department, Lilly agreed to plead guilty to one misdemeanor violation of the Food, Drug and Cosmetic Act related to the off-label promotion of Zyprexa between 1999 and 2001. The guilty plea says Lilly promoted the drug in elderly people as treatment for dementia, including Alzheimer's, although the drug isn't approved for such use.The company said it disagrees with and doesn't admit to the allegations, but would settle the dispute. General Counsel Robert A. Armitage noted in October the probe "has been ongoing for five years and we now have a heightened sense of responsibility to all our stakeholders to intensify efforts to resolve these issues."Lilly will also face a period of increased regulation as part of the settlement -- it has entered a corporate integrity agreement with the Health and Human Services Department. The agreement requires the company to maintain its compliance program and undertake a set of obligations related to integrity over five years. The deal also provides for a third-party review of the company's policies...Insurers, pension funds and unions have been among those seeking compensation from Lilly, accusing it of concealing Zyprexa's tendency to cause weight gain and diabetes and of marketing the drug for unapproved uses

Source: http://online.wsj.com/article/SB123201838370585347.html?mod=googlenews_wsj

28,085 Signatures Against TeenScreen. Petition: http://www.petitiononline.com/TScreen/petition.html Video: